Physician profile
Greg S Cohen
NPI 1669447348
$7,563.68
in general payments reported to CMS, 2019-2025
19 companies · $765 in 2025
The $765 reported for 2025 was more than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,731 · 2020: $141 · 2021: $136 · 2022: $71.02 · 2024: $720 · 2025: $765.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,485.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,485.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $5,029.99 | 2019-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $602.46 | 2019-2025 | Xifaxan |
| Abbvie INC. | $462.01 | 2019-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $389.94 | 2019-2025 | Entyvio, Eohilia |
| Janssen Biotech, INC. | $329.76 | 2019-2025 | Tremfya, Stelara |
| Ucb, INC. | $144.05 | 2019-2020 | |
| Ethicon US, LLC | $92.68 | 2019 | |
| Phathom Pharmaceuticals, INC. | $87.16 | 2024 | Voquezna |
| Lilly USA, LLC | $83.38 | 2024-2025 | Omvoh |
| Ardelyx, INC. | $61.98 | 2024-2025 | Ibsrela |
| Braintree Laboratories, INC. | $51.24 | 2019 | |
| Ironwood Pharmaceuticals, INC | $49.72 | 2019 | |
| Madrigal Pharmaceuticals | $48.67 | 2025 | Rezdiffra |
| Concordia Pharmaceuticals INC. | $41.20 | 2019 | |
| Allergan, INC. | $28.59 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $24.23 | 2024 | Cyltezo |
| Sandoz INC. | $17.91 | 2024 | Hyrimoz |
| Qol Medical, LLC | $15.99 | 2025 | Sucraid |
| Romark Laboratories, Lc | $2.72 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Greg Cohen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.